Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Introduction to R01:11

Introduction to R

534
R is a powerful software environment for statistical computing and graphics. Originating as an implementation of the S language, developed at Bell Laboratories, R has evolved into a robust, open-source statistical software favored by statisticians and data scientists worldwide. Its comprehensive suite includes data manipulation, calculation, and graphical display capabilities, making it versatile for data analysis and visualization. Its programming language is at the core of R's...
534
Relative Risk01:12

Relative Risk

274
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
274
Blinding01:11

Blinding

2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

156
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable Selection in Multistate Models for Correlated Data With Application in a COVID-19 Vaccination Study.

Statistics in medicine·2026
Same author

Assessment of early return to drinking in surviving patients with alcohol-associated hepatitis.

Alcohol, clinical & experimental research·2026
Same author

Non-Parametric Estimation for Semi-Competing Risks Data With Event Misascertainment.

Statistics in medicine·2025
Same author

Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone.

Hepatology (Baltimore, Md.)·2024
Same author

Unique urine and serum metabolomic signature in patients with excessive alcohol use: An exploratory study.

Alcohol, clinical & experimental research·2024
Same author

Mechanisms of Antihypertensive Effect of Chlorthalidone in Advanced Chronic Kidney Disease: A Causal Mediation Analysis.

Clinical journal of the American Society of Nephrology : CJASN·2024

Related Experiment Video

Updated: Aug 16, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

A reference-free R-learner for treatment recommendation.

Junyi Zhou1, Ying Zhang2, Wanzhu Tu3

  • 1Design and Inovation, 7129Amgen Inc., Thousand Oaks, CA, USA.

Statistical Methods in Medical Research
|December 21, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new R-learner method for personalized treatment recommendations using observational data. The approach accurately identifies optimal treatments, aligning with clinical guidelines in real-world trials.

Keywords:
Heterogeneous treatment effectR-learnersimplextreatment recommendation

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

489
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Aug 16, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

489
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Biostatistics and Bioinformatics
  • Computational Biology
  • Clinical Informatics

Background:

  • Precision medicine aims to tailor treatments to individual patient characteristics.
  • Deriving causal treatment effects from observational data with multiple options is complex.
  • Patient heterogeneity necessitates advanced methods for optimal treatment assignment.

Purpose of the Study:

  • To develop a novel, reference-free R-learner method for personalized treatment recommendations.
  • To address challenges in causal inference and patient heterogeneity in observational studies.
  • To provide evidence-based treatment guidelines for multiple therapeutic options.

Main Methods:

  • Proposed a reference-free R-learner algorithm utilizing a simplex approach.
  • Conducted extensive simulations to validate the accuracy and robustness of the method.
  • Applied the R-learner to analyze data from the Systolic Blood Pressure Intervention Trial (SPRINT).

Main Results:

  • The proposed R-learner demonstrated accurate treatment recommendations in simulations.
  • Recommendations consistently corresponded to optimal treatment outcomes across various scenarios.
  • Analysis of SPRINT data yielded recommendations aligned with established clinical guidelines.

Conclusions:

  • The reference-free R-learner is a robust method for personalized treatment recommendations.
  • The approach effectively handles causal inference and patient heterogeneity in observational data.
  • This method supports evidence-based decision-making in precision medicine and clinical practice.